Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine compound in hospitalized adults with COVID-19
IRCT20200504047298N3Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of diphenhydramine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Clinical findings in COVID-19 patients, Paraclinical findings in COVID-19 patients and 3 more. Started Aug 2020; status: completed.
02
Drugs
diphenhydramine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200504047298N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200504047298N3.